Lipella Pharmaceuticals Accounts Payable

Lipella Pharmaceuticals (LIPO) currently reports a accounts payable of $460M as of September 2025. That compares with $460M in the prior-year period — up 0.7% year over year. Use the charts on this page to explore Lipella Pharmaceuticals's accounts payable history and peer comparisons.

Lipella Pharmaceuticals's accounts payable increased from $460M to $460M — a 0.7% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lipella Pharmaceuticals reported $460M in accounts payable as of September 2025. That compares with $460M in the prior-year period — up 0.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $460M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lipella Pharmaceuticals, and consider following LIPO for alerts when major investors trade the stock.